OF
OLMA icon

Optimize Financial’s Olema Pharmaceuticals OLMA Stock Holding History

Optimize Financial’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$256K Sell
20,496
-71
-0.3% -$951 0.09% 259
2026
Q1 		$307K Buy
+20,567
New +$458K 0.15% 260

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Optimize Financial's OLMA Position: Q2 2026 in Review

Optimize Financial reduced its Olema Pharmaceuticals (OLMA) stake by 0.35% in Q2 2026, selling an estimated $951 and leaving 20,496 shares worth $256K. The position accounts for 0.09% of the portfolio, ranked #259.

Optimize Financial first reported a position in OLMA in Q1 2026 and has held it in 2 quarters since. The position peaked at $307K in Q1 2026. 186 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Optimize Financial held 20,496 shares of Olema Pharmaceuticals worth $256K as of Q2 2026.
  • Optimize Financial sold 71 Olema Pharmaceuticals shares in Q2 2026, an estimated $951.
  • Olema Pharmaceuticals made up 0.09% of Optimize Financial's portfolio in Q2 2026, its #259 holding.
  • Optimize Financial first reported a position in Olema Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Optimize Financial's Olema Pharmaceuticals position peaked at $307K in Q1 2026.
  • 186 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Optimize Financial's 13F filing for Q2 2026, filed 27 Aug 2026.